6.1 - 11.1

3.9 - 11.1

P

logistics

n

415

510

Age, median [Q1, Q3]

55.00 [44.00, 65.00]

54.00 [43.00, 65.00]

<0.001*

0.407

Male, n

249

307

1.000

/

Male, (%)

60.00%

60.20%

ethnicity

white, n

256

312

white, (%)

61.69%

61.18%

BLACK/AFRICAN AMERICAN, n

51

59

BLACK/AFRICAN AMERICAN, (%)

12.29%

11.57%

AMERICAN INDIAN/ALASKA NATIVE, n

2

2

AMERICAN INDIAN/ALASKA NATIVE, (%)

0.48%

0.39%

PORTUGUESE, n

4

4

PORTUGUESE, (%)

0.96%

0.78%

UNKNOWN, n

50

63

UNKNOWN, (%)

12.05%

12.35%

ASIAN, n

12

14

ASIAN, (%)

2.89%

2.75%

OTHER, n

16

21

OTHER, (%)

3.86%

4.12%

HISPANIC/LATINO, n

13

21

HISPANIC/LATINO, (%)

3.13%

4.12%

UNABLE TO OBTAIN, n

11

14

UNABLE TO OBTAIN, (%)

2.65%

2.75%

Aps III, median [Q1, Q3]

62.00 [43.00, 87.50]

59.00 [41.00, 84.00]

0.134

/

inSOFA, median [Q1, Q3]

1.00 [0, 4.00]

1.00 [0, 4.00]

0.986

/

▲SOFA, median [Q1, Q3]

1.00 [−1.00, 3.00]

1.00 [−1.00, 3.00]

0.992

/

Glu_meana (mmol/L), median [Q1, Q3]

7.88 [7.00, 8.92]

7.55 [6.42, 8.61]

<0.001*

/

Glu_cvb, median [Q1, Q3]

0.23 [0.17, 0.33]

0.22 [0.16, 0.31]

0.126

/

Glu_frequency* (n/day), median [Q1, Q3]

4.59 [3.63, 6.34]

4.43 [3.24, 6.10]

0.088

0.243

LOS in ICUc, median [Q1, Q3]

5.83 [3.14, 13.74]

4.95 [2.96, 11.67]

0.072

/

LOS in hospitald, median [Q1, Q3]

17.76 [9.99, 28.95]

16.62 [9.03, 26.71]

0.091

/

antibiotic day, median [Q1, Q3]

1.00 [0, 3.00]

1.00 [0, 3.00]

0.610

/

die, n

204

241

0.597

/

die, (%)

49.16%

47.25%

blood-infection, n

123

142

0.004

/

blood-infection, (%)

29.64%

27.84%

Abdominal-infection, n

60

71

0.850

/

Abdominal-infection, (%)

14.46%

13.92%

urinary-infection, n

45

57

0.916

/

urinary-infection, (%)

10.84%

11.18%

respiratory-infection, n

71

78

0.473

/

respiratory-infection, (%)

17.11%

15.29%

diabetes, n

135

148

0.252

/

diabetes, (%)

32.53%

29.02%

hypoglycemia, n

7

11

0.642

/

hypoglycemia, (%)

2.81%

3.58%

die, n

62

68

0.5063

/

die, (%)

14.94%

13.33%

hyperlipidemia, n

85

96

0.56

/

hyperlipidemia, (%)

34.14%

31.27%